Loading...

THYROCARE Thyrocare Technologies Ltd Other Situations Announcement

Thyr

THYR

Thyrocare Technologies Ltd

(THYROCARE)

2025 Announcement

Encumbrance on shares

Tax assessment notice

Trading Window Closure

Equity Investment

Earnings Conference Call

Newspaper Publication

Analyst / Investor Call

Regulatory compliance update

Investor Presentation

Unaudited results

Unaudited Financial Results

Unaudited Results

Brand ambassador appointment

Analyst / Investor Call

Board Meeting Intimation

Auditor Name Change

Regulatory Compliance

Management Appointment

Regulatory Compliance

Appointment of COO

Promoter encumbrance disclo...

Disclosure under Reg. 31(1)...

Regulatory disclosure

Regulation 29(2) Disclosure

Bonus Issue 2:1

Resignation of Senior Manag...

Bonus Equity Issue

Increase in authorised shar...

BSE Clarification

Promoter Encumbrance Update

Acquisition Disclosure

Share Acquisition Disclosure

Stake Sale Announcement

Earnings Call Transcript

Postal Ballot Notices

Financial Results Published

Investor Call Recorded

Bonus Issue Announced

Interim Dividend Record

Dividend Announcement

Internal Auditor Re-Appointed

Financial Results Update

Earnings Presentation

Financial Results

Board Meeting Outcome

Regulatory Compliance

Employee Stock Options

Postal Ballot Notice

Leadership Change

Management Appointment

Earnings Call Transcript

Earnings Call Update

Financial Results Published

Earnings Call Recording

Management Changes

Management Changes

Management Changes

CFO Resignation

Directorate Change

Investor Presentation

Analyst Meet Notification

Compliance Certificate

Newspaper Publication

AGM Announcement

Tax Hearing Notice

Newspaper Publication

Share Transfer Notice

Capital Infusion

Secretarial Compliance Report

Earnings Call Transcript

Financial Results Published

Earnings Call Audio

Auditors Appointment

Investor Presentation

Earnings Call Invite

Compliance Update

Equity Investment

Earnings Call Transcript

Financial Results Published

Earnings Call Audio

Financial Results Q3

Management Update

Management Change

Stock Options Granted

Financial Results Presentation

Earnings Call Invite

Regulatory Compliance

Postal Ballot Notice

Equity Investment

Unclaimed Shares Notice

Earnings Call Transcript

Financial Results Update

Earnings Call Update

Earnings Presentation

Q2 FY25 Results

Earnings Call Update

Earnings Call Invitation

Acquisition Complete

Director Cessation

Business Acquisition

Business Acquisition

Director Cessation

Newspaper Publication

Business Acquisition

earnings call transcript

Newspaper Advertisement

Investor Presentation

Earnings Conference Call

Business Transfer Agreement

Clarification Announcement

Correction of Shares

Dividend Transfer to IEPF

Annual Secretarial Complian...

Earnings Call Transcript

Newspaper Advertisements - ...

Financial Results

Investor Conference

Directors and Auditors Appo...

Appointment of Directors & ...

Financial Presentation

Earnings Conference Call

Compliance Certificate Subm...

Compliance Certificate Subm...

Resignation Announcement

Income Tax Rectification

Rectification Order

Acquisition Completed

Rectification of Assessment...

Financial Results Published

Earnings Call - Audio Recor...

Financial Results

Acquisition of Think Health...

Appointment of Mr. Rahul Guha

Investor Conferences

Newspaper Advertisement

Investor Meeting

Financial Results

Earnings Call - Audio Recor...

Financial Results Announcement

Assessment Order

Earnings Conference Call

Joint Venture in Tanzania

Investor Conference

Investor Meeting

Conference Call

Analyst Meetings

Financial Statements

Investor Meetings

Investor Meetings

Analyst Meeting

Newspaper Publication

Appointments, Resignations

Meeting with Investors/Anal...

Analyst Meetings

Equity Carve-outs

Analyst / Investor Meet

Investor Meetings

Virtual Meeting

Earnings Conference Call

Advertisement of Financial ...

Management Changes

Appointments, Resignations

Presentation of Results

Earnings conference call

Director Resignation

Virtual Meeting

External Links:

Data:

Promoter encumbrance on Thyrocare shares remains at 60.93% (3,23,23,232 shares) with no new encumbrances; API Holdings redeemed ₹500 crore Series 2 NCDs; regulator disclosures updated.

AI Assistant

Thyrocare Technologies Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.